Search Results for "Bevacizumab"

Most Relevant

Most Recent

Anti-VEGF, A Biography: Part 3

AAO 2021 Late Breakers: DAVIO and NORSE-2

Navigated Grid Laser Treatment After Bevacizumab Failure in BRVO

Stefan Dithmar, MD, Mira Ruppenstein, MD, Thomas Ach, MD, Alexandra Hoeh, MD

New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC

Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

Diabetic TRD

Dimitra Skondra, MD, PhD

Systemic Levels of Anti-VEGF: What Available Data Reveal

Robert Avery MD, PhD

ASSESS Study - 24 Months

Rishi P. Singh, MD

Trials on Steroids for Diabetic Eye Disease

Albert J. Augustin, MD

Anti-VEGF Therapy and Vitrectomy in Severe PDR

Diabetic Tractional Retinal Detachment

Colin McCannel, MD, Michael A. Klufas, MD

Protocol AC: Step Therapy in DME

Chirag D. Jhaveri, MD; and Prof. Ramin Tadayoni

Protocol AC Guides DME Treatment Approaches

Chirag D. Jhaveri, MD

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Steven Yeh, MD, Kevin J. Blinder, MD

Protocol T 2-Year Data

Neil Bressler, MD, Tim Murray, MD

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Switch Case: Massive PED (Part 2)

Yasha S. Modi, MD

Real-World Switch Case: Wet AMD Therapy in a Patient Averse to Injections

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Real-World Step Therapy Case: A Challenging DME Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC

Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

Anti-VEGF, A Biography: Part 3

John D. Pitcher III, MD; Bob Avery, MD; David Brown, MD; Jeffrey Heier, MD; Nancy Holekamp, MD; Kirk Packo, MD; Phillip Rosenfeld, MD, PhD; and Bob Vitti, MD